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OBJECTIVES: Intestinal ischemia/reperfusion often leads to acute lung injury and multiple organ failure.
Ischemic preconditioning is protective in nature and reduces tissue injuries in animal and human models.
Although hematimetric parameters are widely used as diagnostic tools, there is no report of the influence of
intestinal ischemia/reperfusion and ischemic preconditioning on such parameters. We evaluated the
hematological changes during ischemia/reperfusion and preconditioning in rats.
METHODS: Forty healthy rats were divided into four groups: control, laparotomy, intestinal ischemia/reperfusion
and ischemic preconditioning. The intestinal ischemia/reperfusion group received 45 min of superior mesenteric
artery occlusion, while the ischemic preconditioning group received 10 min of short ischemia and reperfusion
before 45 min of prolonged occlusion. A cell counter was used to analyze blood obtained from rats before and
after the surgical procedures and the hematological results were compared among the groups.
RESULTS: The results showed significant differences in hematimetric parameters among the groups. The
parameters that showed significant differences included lymphocyte, white blood cells and granulocyte counts;
hematocrit; mean corpuscular hemoglobin concentration; red cell deviation width; platelet count; mean platelet
volume; plateletcrit and platelet distribution width.
CONCLUSION: Themost remarkable parameters were those related to leukocytes and platelets. Some of the data,
including the lymphocyte and granulocytes counts, suggest that ischemic preconditioning attenuates the effect
of intestinal ischemia/reperfusion on circulating blood cells. Our work contributes to a better understanding of
the hematological responses after intestinal ischemia/reperfusion and IPC, and the present findings may also be
used as predictive values.
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& INTRODUCTION
Ischemic injury results from the interruption of blood
flow and causes damage to active tissues; ischemic reperfu-
sion injury (IRI) occurs after the restoration of blood flow,
leading to additional tissue injury (1). In 1986, Parks and
Granger (2) reported that reperfusion is more harmful than
ischemia alone. In particular, the tissue damage that is
caused by ischemia and reperfusion in the intestine is
associated with high morbidity and mortality in surgical
patients. IRI occurs in cases of abdominal aortic aneurysm
surgery, hemorrhagic shock, acute mesenteric ischemia
(AMI), strangulated hernia, neonatal necrotizing enteroco-
litis, cardiopulmonary bypass and organ transplantation (3).
Among the internal organs, the intestine is most sensitive to
IRI (1). Intestinal IRI can lead to damage in the intestinal
mucosa and the release of various inflammatory mediators,
potentially resulting in the development of systemic
inflammatory response syndrome (SIRS) and further lead-
ing to multiple organ failure (MOF), especially acute lung
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injury (ALI) (4-7). Ischemia-reperfusion causes local and
systemic changes in hemodynamics, endothelial function,
microcirculation, fluid equilibrium and metabolic home-
ostasis while also inducing the complement and inflamma-
tory pathways (8-14). In an attempt to attenuate this
damage, several treatment modalities have been applied in
various animal models of IRI, such as hypothermia,
antioxidants, ischemic preconditioning (IPC) and modula-
tion of inflammatory mediators and adhesion molecules.
Among these approaches, IPC seems to be the most
promising against reperfusion injury, as it increases the
bowel’s tolerance against the damage caused by ischemia
followed by reperfusion (15-17).
In 1986, Murry et al. introduced the concept of IPC as
short episodes of ischemia followed by short periods of
reperfusion preceding a prolonged ischemia; this approach
was shown to protect organs against subsequent longer
ischemia (18). IPC of the intestine was first described by
Hotter et al. in 1996 (19) and subsequent studies have
confirmed this phenomenon. Studies in shock models show
that IPC before intestinal ischemia causes a significant
reduction in the inflammatory response in the lungs and
intestinal injuries due to hemorrhagic shock (20). However,
the precise mechanism by which IPC confers protection to
the intestine remains unclear.
Blood is the most accessible component of the vertebrate
body fluid system and has frequently been examined to
assess physiological status (21). Hematimetric parameters
have long been used as diagnostic tools for a large number
of diseases, such as leukemias, anemias and infectious
diseases. However, few studies have collectively addressed
the prognostic values of these parameters using multivariate
analysis and to our knowledge, no studies have addressed
IPC. The purpose of this study was to obtain a basic
knowledge of the hematological factors after IRI and IPC in
rats. In this prospective study, we evaluated the significance
of routine blood parameters after intestinal ischemia and
preconditioning in rats, the results of which could help in
the early diagnosis of IRI and in understanding how IPC
affects blood components.
& MATERIALS AND METHODS
Experimental subjects and sample collection
Male Wistar rats without inflammatory disease and
weighing 250–350 g were collected from the animal house
of the Faculdade de Medicina da Universidade de Sa˜o Paulo
(FMUSP), Sa˜o Paulo State, Brazil. The project was approved
by the Ethics Committee of FMUSP (Protocol No. 8186) for
the use of rats as experimental subjects. The animals were
provided access to food and water ad libitum until the time
of the experiment.
Experimental groups
Forty rats were randomly allocated into the following
four groups (Figure 1), where n represents the number of
animals per group:
1- The control group (C) (n = 10), without any surgical
procedure.
2- The sham laparotomy group (LAP) (n = 10), without
clamping of any artery, but receiving the same surgical
procedure except for the clamping.
3- Ischemia/reperfusion (IR) group (n = 10), submitted to
superior mesenteric artery occlusion (SMAO) for
45 min followed by 120 min of reperfusion.
4- Ischemic preconditioning (IPC) group (n = 10), sub-
mitted to a 10-min period of SMAO followed by 10-min
reperfusion immediately before 45 min of ischemia and
120 min of reperfusion, as in the IR group.
Hematological analyses
We collected 20 ml of blood from the tails of all animals
before and after surgery and injected the samples into a
Figure 1 - Experimental groups and their times of ischemia and reperfusion, where n represents the number of animals per group.
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veterinary automated cell counter (BC-2800Vet, Shenzhen
Mindray Bio-Medical Electronics Co., Nanshan, China). The
analyzed hematimetric parameters included the total
erythrocyte count (RBC), total white blood cell (WBC)
count, hematocrit (HCT) level, hemoglobin (Hb) concentra-
tion, erythrocyte indices as mean corpuscular volume
(MCV), mean corpuscular hemoglobin (MCH), mean cor-
puscular hemoglobin concentration (MCHC), platelet (PLT)
count, mean platelet volume (MPV), platelet distribution
widths (PDW), plateletcrit (PCT) and WBC differential
count (22,23).
Surgical procedures
The surgical procedures were performed in the
Laboratory of Surgical Physiopathology (LIM-62), depart-
ment of Surgery, FMUSP. Rats from all of the groups were
anesthetized with intraperitoneal (i.p.) injections of sodium
pentobarbital (45 mg/kg) and ketamine (80 mg/kg) +
xylazine (7 mg/kg) and their core body temperatures were
maintained at 37 C˚. After midline laparotomy, the superior
mesenteric artery was isolated near its aortic origin. During
this procedure, the intestinal tract was placed between
gauze pads that had been soaked with warmed 0.9% NaCl
solution. In rats from the IR group, the superior mesenteric
artery was clamped, resulting in total occlusion of the artery
for 45 min. After the time of occlusion, the clamps were
removed and blood samples were collected from the tail
after 120 min of reperfusion. In the rats of the IPC group, the
ischemic procedure described above was preceded by
10 min of clamping followed by 10 min of reperfusion.
Statistical analysis
For statistical analysis, the data were first checked for
normality by applying the D9Agostino & Pearson omnibus
normality test. The data were normalized and outliers were
removed, based on the Thompson tau technique; then,
normality was reconfirmed with the above-mentioned
normality test. Variance analysis (one-way ANOVA) was
used to determine the difference between the groups and
the Tukey-Kramer test was used to compare and determine
the means that differed significantly from each other using
the Graph Pad Prism program (V.6.0c). Values with p,0.05
were considered significant.
& RESULTS
The hematological parameters of the control, laparotomy,
ischemia/reperfusion and IPC groups are summarized in
Supplementary Table 1.
All of the surgical groups (LAP, IR and IPC) showed a
remarkably smaller amount of lymphocytes than did the
control group. Among the surgical groups, the IR group
showed a decrease in lymphocyte count (p= 0.0021) com-
pared with the LAP group; however, an increase was noted
in the IPC group (p= 0.0171) compared with IR group
(Figure 2-A).
The WBC counts showed a significant increase in both the
IR (p= 0.0005) and the IPC (p= 0.0074) groups compared
with the control group (Figure 2-B). The elevation in WBCs
was more prominent in the IR group than in the IPC group.
A significant increase in the granulocyte count was
observed in the LAP, IR and IPC groups compared with
the controls; there was also an increase in the IR group
compared with the LAP group (p= 0.0015), whereas the IPC
group showed a significant reduction (p= 0.0168) compared
with the IR group, almost approaching the level of the LAP
group (Figure 2-C).
Platelets showed a significant difference between the IR
and IPC groups. The PLT counts were higher (p= 0.0340) in
the IR group than in the IPC group (Figure 2-D) and the
MPV also showed a significantly increased value in the IR
(p= 0.0096) and IPC (p=,0.0001) groups compared with the
controls. In preconditioned rats, the MPV was higher than
that in LAP (p= 0.0004) and IR rats (p= 0.0485) (Figure 2-E).
The PDW was significantly greater in IPC rats compared to
all of the other groups. The p-values for the IPC group
compared with the control, LAP and IR groups are 0.0003,
0.0015 and 0.0011, respectively (Figure 2-F).
The levels of monocytes, RBCs, Hb, MCV and MCH were
not influenced significantly in any experimental group. The
HCT level was increased (p= 0.0082) in the IR group
compared with the control group (Figure 1-A, supplemen-
tary). The MCHC was decreased in the IR group (p= 0.0111)
compared with the controls, whereas there was an increase
in the MCHC value in the IPC group (p= 0.0111) compared
with the IR group, which restored the MCHC value to a
normal level (Figure 1-B, supplementary). The red cell
deviation width was higher (p= 0.0152) in the IPC group
than the control group, although no other group showed a
significant difference (Figure 1-C, supplementary). Both the
IR and IPC groups showed significant differences regarding
their PCT levels, whereas the remaining groups did not
show any significant differences. The PCT level was higher
(p= 0.0264) in the IR group compared with the IPC group
(Figure 2-D).
& DISCUSSION
IPC has been studied as a protective strategy against IRI
in intestinal models (19,20). In humans, prolonged jejunal
ischemia (45 min) followed by reperfusion results in
intestinal barrier integrity loss, which is accompanied by a
significant translocation of endotoxins. These phenomena
result in an inflammatory response that is characterized by
complement activation, endothelial activation, neutrophil
sequestration and the release of pro-inflammatory media-
tors into circulation (24). A comparison of the effect of IR
and IPC on blood parameters has not been made using the
45-min SMAO model in rats. Lymphocyte loss and
dysfunction have been consistently reported in animal
models of both SIRS and sepsis (25) and preventing
lymphocyte dysfunction, specifically lymphocyte apoptosis
following sepsis, has been shown to improve survival after
sepsis (26). Recently, a decrease in the lymphocyte percen-
tage was observed following IR and local and remote IPC in
a rat model with temporary supraceliac aortic clamping (27).
IPC also prevented lymphocyte loss compared with that
observed in the IR group in our study.
We observed a significant increase in the WBC count after
IR. Postoperative leukocytosis represents a normal physio-
logic response to surgery (28). However, an augmentation in
the WBC count has been viewed as a predictor of ischemic
stroke (29). This increase is due to the marked elevation of
leukocyte activation, as previously described in myocardial
ischemia and reperfusion in dogs (30). The increased
number of granulocytes after ischemic strokes leads to tissue
damage, as these cells are implicated in the early responses of
the hemostatic and inflammatory processes (31). Intestinal
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Figure 2 - Distribution of the hematimetric parameters in the four experimental groups. (A) Lymphocyte count, (B) WBC count (C)
Granulocyte count, (D) Platelet count, (E) MPV and (F) PDW. (***p,0.001; **p,0.001 to 0.01; *p,0.01 to 0.05).
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ischemia is characterized by the production of cytokines (32)
and the sequestration of polymorphonuclear neutrophils
(PMNs) into the ischemically damaged tissue. The comple-
ment system also contributes to the attraction of neutrophils
to ischemically damaged areas (33), where neutrophil-
released myeloperoxidase (MPO) and other proinflammatory
mediators further contribute to IR-induced tissue damage
(34). Figure 2-C clearly shows a significant reduction in
circulating granulocytes of the IPC group compared with the
IR group, suggesting a protective aspect of IPC.
With the exception of the MCHC values, our results
concerning RBCs, Hb, MCV, MCH and HCT are similar to
those of a study using a canine model to investigate limb IR,
with or without cooling (35). Dehydration during surgery or
fluid sequestration due to edema can result in a higher-than-
normal HCT level (36). This increase was more prominent in
the IR group and showed no significant difference in any
other group. Similarly, an increase in HCT was observed in
the IR compared with local IPC and remote IPC groups in a
similar model using temporary supraceliac aortic clamping
(27).
Platelets also participate in ischemic strokes (37) and IR-
mediated tissue damage (38) through the modulation of
leukocyte function and the generation of free radicals and
proinflammatory mediators, such as thromboxane (TxA2),
leukotrienes, serotonin, platelet factor-4 and platelet-
derived growth factor (PDGF) (39,40). Similar to leukocytes,
the expression of P-selectin on the platelet surface con-
tributes to rolling and firm adherence to the vascular
endothelium and in the interaction with leukocytes during
post-ischemic reperfusion, resulting in increased expression
of adhesion molecules, the generation of superoxide and the
phagocytic activity of leukocytes (39,41). The inhibition of
platelet adhesion by the administration of an anti-fibrinogen
antibody was shown to decrease short-term liver injury after
ischemia. In addition, platelet-derived serotonin is a
mediator of tissue repair after hepatic normothermic
ischemia in mice (42,43). We observed a significant decrease
in platelets in the IPC group compared with the IR group.
However, the role of platelets in the progression of tissue
damage after IR injury remains unclear. A recent study
showed that platelet-deficient mice showed significant
reductions in damage to their villi in response to IR
compared with mice with normal platelet counts (44).
Previous studies showed that the MPV was higher when
there was destruction of platelets associated with inflam-
matory bowel disease (45), whereas other studies showed
that the MPV was not associated with stroke severity or
functional outcomes (46). The activation of platelets leads to
morphologic changes, including pseudopodia formation
and the development of a spherical shape. Platelets with
an increased number and size of pseudopodia differ in size,
possibly affecting the PDW. Indeed, we found an inverse
relationship between the PLT count and MPV value after IR
and IPC, which suggests that IPC lowers the PLT count but
increases the MPV value. However, a recent study in
patients who underwent surgical intervention for acute
mesenteric ischemia showed an increase in MPV and a
decrease in PLT count in non-surviving patients compared
with surviving patients (47). In the IR group, we found an
increase in the PLT count and a decrease in the MPV value,
in contrast to this previous study. This discrepancy could be
attributed to different occlusion models because AMI
patients can present partial vascular occlusions that last
for less-precise amounts of time. In addition, we cannot
correlate this change with mortality rate, as the model
involving 45 min of intestinal ischemia in rats has been
considered to be free of mortality (48), whereas the ischemic
period and severity varies among clinical conditions,
leading to higher morbidity and mortality. For example,
AMI has an overall mortality of 60% to 80% and the
reported incidence increases over time (49,50), mostly
because of the continued difficulty in recognizing this
condition (50). The effect of IPC on these parameters with
AMI requires further validation in humans.
In summary, our results demonstrate that IPC before
intestinal IR provoked significant alterations in hemati-
metric parameters in the IPC group compared with that in
the IR group, mainly comprising decreases in the granulo-
cyte count and PCT count and increases in the lymphocyte
count and the MPV.
The results of the present study indicate that 10 min of
IPC before 45 min of intestinal IR alter the hematimetric
parameters, suggesting that IPC attenuates the effect of IR in
circulating blood cells.
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Supplementary Figure 1 - supplementary. Distribution of hematimetric parameters in the four experimental groups. (A) HCT, (B) MCHC,
(C) Red cell distribution width and (D) PCT. (**p,0.001 to 0.01; *p,0.01 to 0.05).
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